Filtered By:
Infectious Disease: Coronavirus
Nutrition: Calcium

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 327 results found since Jan 2013.

Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea
CONCLUSION: In South Korea, beta-blockers exhibited potential benefits in lowering the incidence of COVID-19 among hypertensive patients. Furthermore, CCBs may lower the hospital mortality rate among hypertensive COVID-19 patients. These findings were also applied to the general adult population, regardless of hypertension.PMID:34164954 | PMC:PMC8236350 | DOI:10.3349/ymj.2021.62.7.577
Source: Yonsei Medical Journal - June 24, 2021 Category: Universities & Medical Training Authors: Tak Kyu Oh Hyoung Won Cho Jung Won Suh In Ae Song Source Type: research

Standardized out-patient diagnosis and treatment process for osteoporosis clinics during the COVID-19 pandemic.
Authors: Zou J, Song DW, Niu JJ, Shi JW, Yang HL Abstract Since the end of 2019, China and other regions around the world have been facing a pandemic of novel coronavirus pneumonia (COVID-19). The virus is highly transmissible, and the human population is generally susceptible. Most patients with osteoporosis are postmenopausal women or elderly people with hypoimmunity, so the osteoporosis clinic has become a new hotspot for corona virus infection. During the COVID-19 pandemic, it is necessary to establish standardized out-patient protocols to provide safe and effective treatment for osteoporosis patients and medic...
Source: European Review for Medical and Pharmacological Sciences - June 5, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research

Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea
CONCLUSION: In South Korea, beta-blockers exhibited potential benefits in lowering the incidence of COVID-19 among hypertensive patients. Furthermore, CCBs may lower the hospital mortality rate among hypertensive COVID-19 patients. These findings were also applied to the general adult population, regardless of hypertension.PMID:34164954 | DOI:10.3349/ymj.2021.62.7.577
Source: Yonsei Medical Journal - June 24, 2021 Category: Universities & Medical Training Authors: Tak Kyu Oh Hyoung Won Cho Jung Won Suh In Ae Song Source Type: research